Study of Anlotinib in Patients With Gastric Cancer(ALTER0503)

Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer.

NCT03144843 ·Status: UNKNOWN ·Phase: PHASE2

A Study of Anlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma

NCT04385550 ·Status: UNKNOWN ·Phase: PHASE3

An Exploratory Study of Immunotherapy Combined With Anlotinib and Chemotherapy in Perioperative Treatment of LAGC

NCT05800080 ·Status: UNKNOWN ·Phase: NA

A Phase I Trial of Simmitinib in Advanced Solid Tumors

NCT04058587 ·Status: UNKNOWN ·Phase: PHASE1

A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression

NCT06939452 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Efficacy and Safety of AMN107 in Patients With GastroIntestinal Stromal Tumors (GIST) Who Have Failed Both Imatinib and Sunitinib

NCT00718562 ·Status: COMPLETED ·Phase: PHASE2

Gentuximab Combined With Paclitaxel Compared With Placebo Combined With Paclitaxel for Gastric Adenocarcinoma.

NCT05919381 ·Status: UNKNOWN ·Phase: PHASE3

TAS-102 and Anlotinib in ≥3 Lines mGC

NCT05029102 ·Status: RECRUITING ·Phase: PHASE2

Tislelizumab Plus Anlotinib for Immunotherapy Resistant Gastrointestinal Cancer

NCT04777162 ·Status: UNKNOWN ·Phase: PHASE2

Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma

NCT03801668 ·Status: UNKNOWN ·Phase: PHASE3

Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer

NCT01444521 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Anlotinib Hydrochloride Combined With Nivolumab in the Treatment of Gastric and Esophageal Cancer

NCT04503967 ·Status: UNKNOWN ·Phase: PHASE2

The Safety and Efficacy of PD-1 Monoantrapical Chemotherapy in the Treatment of Local Advanced Stomach Cancer

NCT05000554 ·Status: RECRUITING ·Phase: PHASE2

Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer

NCT03286244 ·Status: UNKNOWN ·Phase: PHASE1

Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors

NCT06947291 ·Status: RECRUITING ·Phase: PHASE2

An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors

NCT01040312 ·Status: COMPLETED

Efficacy and Safety Evaluation of Sintilimab or Placebo in Combination With XELOX as First Line Treatment in Patients With Gastric Cancer

NCT03745170 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Olaparib in Combination With Paclitaxel to Treat Advanced Gastric Cancer.

NCT01924533 ·Status: COMPLETED ·Phase: PHASE3

A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study

NCT05934331 ·Status: RECRUITING ·Phase: PHASE2

Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer

NCT02229058 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study of Albumin-paclitaxel Combined With Apatinib and Camrelizumab in Advanced Gastric Cancer

NCT04286711 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study of AK104 in the First-line Treatment of Locally Advanced Unresectable or Metastatic G/GEJ Adenocarcinoma

NCT05008783 ·Status: COMPLETED ·Phase: PHASE3

A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer

NCT01291407 ·Status: COMPLETED ·Phase: PHASE1

Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC)

NCT04278222 ·Status: RECRUITING ·Phase: PHASE2

Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

NCT01015339 ·Status: UNKNOWN ·Phase: PHASE3